Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Alfonso G Scicli"'
Autor:
Branislava Janic, Austin M Guo, A S M Iskander, Nadimpalli Ravi S Varma, Alfonso G Scicli, Ali S Arbab
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9173 (2010)
Stem cells/progenitors are central to the development of cell therapy approaches for vascular ischemic diseases. The crucial step in rescuing tissues from ischemia is improvement of vascularization that can be achieved by promoting neovascularization
Externí odkaz:
https://doaj.org/article/c070b3aaa56b4c80b2d30ddc2d08d605
Autor:
Bhagelu R. Achyut, Ali S. Arbab, Kartik Angara, Alfonso G. Scicli, Peng Zeng, Robert A. Knight, Roxan Ara, Adarsh Shankar, A. S.M. Iskander
Publikováno v:
Cancer Letters. 369:416-426
Glioblastoma (GBM) is a hypervascular and malignant form of brain tumors. Anti-angiogenic therapies (AAT) were used as an adjuvant against VEGF-VEGFR pathway to normalize blood vessels in clinical and preclinical studies, which resulted into marked h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274709d9e84247bbc2c4670c3a1cec8c
https://doi.org/10.1016/j.canlet.2015.09.004
https://doi.org/10.1016/j.canlet.2015.09.004
Autor:
Li Chen, Fank F Zhang, Katherine H Gotlinger, John C Falck, Alfonso G Scicli, Michal L Schwartzman, Austin M Guo
Publikováno v:
Hypertension. 64
Objective: Compensatory neovascularizaiton is an important adaptation for recovery from critical ischemia. Recent studies identified the CYP4A-20-HETE system as a novel regulator of angiogenic processes. Here, we assessed the contribution of the 20-H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2382752b60b2febb0139fb69a6bf986
https://doi.org/10.1161/hyp.64.suppl_1.338
https://doi.org/10.1161/hyp.64.suppl_1.338
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 109(3):466-472
Mechanical function and coronary hemodynamics were assessed in 73 isolated rabbit hearts randomly subjected to 0, 10, 20, 30, or 45 minutes of 37 degrees C global ischemia and 45 minutes of reperfusion in either a modified Krebs buffer or homologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14a8a47bd48d4d11b4880fec20806f9
Autor:
Ali S. Arbab, Adarsh Shankar, Bhagelu R. Achyut, Asm Iskander, Robert A. Knight, Alfonso G. Scicli, Roxan Ara, Kartik Angara
Publikováno v:
Cancer Research. 75:A23-A23
Glioblastoma (GBM) is considered as hypervascular form of brain tumors. Anti-angiogenic therapies (AAT) were used as an adjuvant against VEGF-VEGFR pathway to normalize blood vessels. Surprisingly, AAT resulted into marked hypoxia and recruited bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbcce5f3ca944986191fb109b6ef67d1
https://doi.org/10.1158/1538-7445.brain15-a23
https://doi.org/10.1158/1538-7445.brain15-a23
Publikováno v:
Hypertension. 23:865-868
We examined the effect of non-antihypertensive doses of the angiotensin-converting enzyme inhibitor ramipril, kinins, and/or nitric oxide on left ventricular hypertrophy in rats with aortic coarctation. We investigated the effect of either HOE 140, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c5faa873503b6809cb4ad900d99cd0
https://doi.org/10.1161/01.hyp.23.6.865
https://doi.org/10.1161/01.hyp.23.6.865
Publikováno v:
Hypertension. 23:919-923
It has been reported that kinins mediate part of the beneficial cardiac effects induced by treatment with angiotensin-converting enzyme inhibitors in situations such as ischemia-reperfusion injury, myocardial infarction, and cardiac hypertrophy. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bdd73e56c7707d8c304e50ac48422d
https://doi.org/10.1161/01.hyp.23.6.919
https://doi.org/10.1161/01.hyp.23.6.919
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 265:H1209-H1214
Vascular tissue contains kallikrein and kallikrein mRNA, suggesting a vascular kallikrein-kinin system. We questioned whether 1) kallikrein concentration varies among large and small vessels; 2) kallikrein is released by vascular tissue; and 3) block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b15ff9e4146c40a64328823efbec744
https://doi.org/10.1152/ajpheart.1993.265.4.h1209
https://doi.org/10.1152/ajpheart.1993.265.4.h1209
Autor:
Nadimpalli Ravi S. Varma, Branislava Janic, Ali S. Arbab, Austin M. Guo, A. S. M. Iskander, Alfonso G. Scicli
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 2, p e9173 (2010)
PLoS ONE, Vol 5, Iss 2, p e9173 (2010)
Background Stem cells/progenitors are central to the development of cell therapy approaches for vascular ischemic diseases. The crucial step in rescuing tissues from ischemia is improvement of vascularization that can be achieved by promoting neovasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c149683097912bade1a5441d1b02a2
http://europepmc.org/articles/PMC2820083
http://europepmc.org/articles/PMC2820083
Autor:
O A Carretero, Alfonso G. Scicli
Publikováno v:
Hypertension. 18:366-371
Inhibitors of two zinc metallopeptidases, angiotensin I converting enzyme (ACE) and neutral metalloendopeptidase-24.11 (EP-24.11), are antihypertensive agents. In this issue of Hypertension, Genden and Molineaux report that yet another peptidase inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4f70f2fb3973fa6af83897426d40c0
https://doi.org/10.1161/01.hyp.18.3.366
https://doi.org/10.1161/01.hyp.18.3.366